Search This Blog

Wednesday, March 30, 2022

Elox to Get Therapeutic Development Award from Cystic Fibrosis Foundation

 Cystic Fibrosis Foundation (CF Foundation) to provide an award of up to $15.9 million for the ongoing ELX-02 clinical program

Expect topline data from cystic fibrosis Phase 2 expansion treatment arms evaluating combination with ivacaftor by the end of the first half of 2022

https://finance.yahoo.com/news/eloxx-pharmaceuticals-announces-therapeutic-development-110000543.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.